{"id":"https://openalex.org/W4415941107","doi":"https://doi.org/10.1016/j.annonc.2025.08.515","title":"81MO Survival and safety of tinengotinib in pooled patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma (CCA)","display_name":"81MO Survival and safety of tinengotinib in pooled patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma (CCA)","publication_year":2025,"publication_date":"2025-09-01","ids":{"openalex":"https://openalex.org/W4415941107","doi":"https://doi.org/10.1016/j.annonc.2025.08.515"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2025.08.515","doi":"https://doi.org/10.1016/j.annonc.2025.08.515","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.515","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2025.08.515","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070323288","display_name":"M.M. Javle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Javle","raw_affiliation_strings":["Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center - Main Building, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center - Main Building, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074966340","display_name":"C-Y.A. Liao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C-Y.A. Liao","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago, United States of America","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100720707","display_name":"Lin Shen","orcid":"https://orcid.org/0000-0003-1134-2922","observed_orcids":["https://orcid.org/0000-0003-1134-2922"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"L. Shen","raw_affiliation_strings":["Department of Gastrointestinal Oncology, Beijing Cancer Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Oncology, Beijing Cancer Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031777309","display_name":"Lionel Aurelien Kankeu Fonkoua","orcid":"https://orcid.org/0000-0001-5560-2103","observed_orcids":["https://orcid.org/0000-0001-5560-2103"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.A. Kankeu Fonkoua","raw_affiliation_strings":["Hematology and Oncology Department, Mayo Clinic - Rochester, Rochester, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology Department, Mayo Clinic - Rochester, Rochester, United States of America","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033837903","display_name":"Christos K Fountzilas","orcid":"https://orcid.org/0000-0003-3837-5644","observed_orcids":["https://orcid.org/0000-0003-3837-5644"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Fountzilas","raw_affiliation_strings":["Gastrointestinal Clinical Disease Team, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Clinical Disease Team, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, United States of America","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100323870","display_name":"Dongliang Li","orcid":"https://orcid.org/0000-0003-1642-4927","observed_orcids":["https://orcid.org/0000-0003-1642-4927"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Li","raw_affiliation_strings":["Medical Oncology Department, City of Hope Comprehensive Cancer Center, Duarte, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, City of Hope Comprehensive Cancer Center, Duarte, United States of America","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082164882","display_name":"Meredith S. Pelster","orcid":"https://orcid.org/0009-0005-2448-3478","observed_orcids":["https://orcid.org/0009-0005-2448-3478"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Pelster","raw_affiliation_strings":["Department of Oncology, Sarah Cannon Research Institute, Nashville, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Sarah Cannon Research Institute, Nashville, United States of America","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102014225","display_name":"Baoshan Cao","orcid":"https://orcid.org/0000-0001-7939-4820","observed_orcids":["https://orcid.org/0000-0001-7939-4820"]},"institutions":[{"id":"https://openalex.org/I4210141942","display_name":"Peking University Third Hospital","ror":"https://ror.org/04wwqze12","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141942"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"B. Cao","raw_affiliation_strings":["Oncology Department, Peking University Third Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Peking University Third Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210141942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048019436","display_name":"Dustin A. Deming","orcid":"https://orcid.org/0000-0003-2394-9836","observed_orcids":["https://orcid.org/0000-0003-2394-9836"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Deming","raw_affiliation_strings":["Carbone Cancer Center Medical Oncology Clinic, University of Wisconsin Carbone Cancer Center, Madison, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carbone Cancer Center Medical Oncology Clinic, University of Wisconsin Carbone Cancer Center, Madison, United States of America","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022820783","display_name":"Farshid Dayyani","orcid":"https://orcid.org/0000-0002-4970-5189","observed_orcids":["https://orcid.org/0000-0002-4970-5189"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Dayyani","raw_affiliation_strings":["Medicine Department, UCI - University of California Irvine - Health Manchester Pavilion, Orange, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Department, UCI - University of California Irvine - Health Manchester Pavilion, Orange, United States of America","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029438350","display_name":"Ping Cheong Huang","orcid":"https://orcid.org/0000-0003-1775-029X","observed_orcids":["https://orcid.org/0000-0003-1775-029X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Huang","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079573168","display_name":"Yuan O. Zhu","orcid":"https://orcid.org/0000-0001-9419-6291","observed_orcids":["https://orcid.org/0000-0001-9419-6291"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Zhu","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100460919","display_name":"Hui Wang","orcid":"https://orcid.org/0000-0003-2699-8086","observed_orcids":["https://orcid.org/0000-0003-2699-8086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Wang","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"X. Du","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X. Du","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114123536","display_name":"L. Neo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Neo","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"K. Hennessy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Hennessy","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (US), Inc., Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (US), Inc., Gaithersburg, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068805925","display_name":"Chien\u2010An Sun","orcid":"https://orcid.org/0000-0001-9041-0537","observed_orcids":["https://orcid.org/0000-0001-9041-0537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.A. Sun","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103188558","display_name":"Fei Wu","orcid":"https://orcid.org/0000-0001-5169-0417","observed_orcids":["https://orcid.org/0000-0001-5169-0417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Wu","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (Nanjing), Inc., Nanjing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Fan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Fan","raw_affiliation_strings":["Clinical Operations, TransThera Sciences (US), Inc., Gaithersburg, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Operations, TransThera Sciences (US), Inc., Gaithersburg, United States of America","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026538331","display_name":"Sarina Anne Piha-Paul","orcid":"https://orcid.org/0000-0001-9455-1660","observed_orcids":["https://orcid.org/0000-0001-9455-1660"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.A. Piha-Paul","raw_affiliation_strings":["Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center - Main Building, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center - Main Building, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.7262,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.75118184,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"36","issue":null,"first_page":"S226","last_page":"S226"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":0.9229999780654907},{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/fgfr-inhibitor-resistance","display_name":"FGFR inhibitor resistance","score":0.753000020980835},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.6230000257492065},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.6510000228881836},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8159999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6819999814033508},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9380999803543091},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.6122999787330627},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5267999768257141},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5166000127792358},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47530001401901245},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4007999897003174},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39570000767707825},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.39430001378059387},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.335999995470047},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31299999356269836},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2996000051498413},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.2815999984741211},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.2759000062942505},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.26339998841285706},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.26159998774528503},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.25360000133514404}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2025.08.515","doi":"https://doi.org/10.1016/j.annonc.2025.08.515","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.515","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2025.08.515","doi":"https://doi.org/10.1016/j.annonc.2025.08.515","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2025.08.515","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387812503","https://openalex.org/W4391095396","https://openalex.org/W7122371572","https://openalex.org/W4317892036","https://openalex.org/W4406869263","https://openalex.org/W4408851319","https://openalex.org/W4409690154","https://openalex.org/W7162525825","https://openalex.org/W4391090904","https://openalex.org/W7204036050"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2025-11-06T00:00:00"}